[Skip to Navigation]
September 1987

Lack of Evidence for Aspirin Use and Prevention of Cataracts

Author Affiliations

From the Dana Center for Preventive Ophthalmology, The Wilmer Institute, The Johns Hopkins University School of Medicine (Drs West, Newland, and Taylor and Ms Muñoz), and the Department of Environmental Health Science, The Johns Hopkins University School of Public Health (Dr Emmett), Baltimore.

Arch Ophthalmol. 1987;105(9):1229-1231. doi:10.1001/archopht.1987.01060090087034

• A population-based cross-sectional survey of 838 men aged 30 years and over was conducted to examine the effect of aspirin, and other potential risk factors, on the prevalence of cataracts. Lens opacities were graded on clinical examination for location (cortical, nuclear, and posterior subcapsular) and severity. The results do not support the claim that large doses of aspirin, or frequent use of aspirin, protects against or retards the growth of lens opacities.